Medicinal

07. 12. 2023

Life Insurance and medical cannabis: What you need to know

Life insurance is a meaningful investment, and is taken out to protect and provide for your loved ones after you pass away. In the UK, 35% of residents currently have life insurance, and in 2021 98% of claims were paid out in full. However, on occasion payouts are withheld, and this can happen for a number of reasons.

28. 11. 2023

The CIC takes the wheel: Medical cannabis driving guidance

The Cannabis Industry Council (CIC) has released guidance for medical cannabis patients to ensure that they act safely, and are treated appropriately, when behind the wheel. Distributed for free in physical leaflet format to attendees at The Patient Conference, which took place earlier this month during Medical Cannabis Awareness Week, this document states the rules and regulations that relate to medical cannabis patients and driving.

24. 11. 2023

Behind the leaf: 5 (more) medical cannabis myths debunked

Releaf returns with another dose of myth-busting revelations. One of the big myths of the past was “cannabis will never be legal because they can’t patent a plant”. Well, here we are in 2023 with multiple patents for cannabis-based medicinal products and a burgeoning legal market. Let’s look at some more of the mistakes people make about medical cannabis, and hopefully, if you hear any of these in the future, you’ll feel prepared to debunk it with the evidence.

24. 11. 2023

FSA slashes daily CBD intake guidance: UK industry reacts

The Food Standards Agency and Food Standards Scotland have updated their advice on the Acceptable Daily Intake (ADI) for cannabidiol in a move that has alarmed the CBD industry. In February 2020, the FSA published advice on CBD consumption for the first time. This guidance explained that consumers should not exceed 70mg of CBD in a 24-hour period. However, this week has seen a dramatic reduction in that number, slashed to 10mg per day for healthy adults, highlighting potential long-term side effects.

22. 11. 2023

Sweet dreams, Sound health: Unraveling the secrets to better sleep

Earlier this month, Self Care Week was celebrated all over the UK - but we think its importance rings true all year round. That’s why we’ve launched our latest blog series: Wellness Wednesday; to take a look at alternative, natural and holistic approaches to improving our wellbeing.

17. 11. 2023

One for the books: European Pharmacopoeia establish a monograph for cannabis flower

It has been announced that the official cannabis flos (flower) monograph will be published in supplement 11.5 of the European Pharmacopoeia in January 2024. This will establish international quality and standards testing and identification processes for cannabis flowers, and its derived products, used in medicinal practices.

09. 11. 2023

Behind the leaf: 5 medical cannabis myths debunked

We've finally reached five years since medical cannabis was legalised in the UK. While there is much to celebrate about, there is much to reflect on and still more ground to gain. One thing that is lagging in the UK is greater awareness about medical cannabis legality and availability. Access is there for anyone who can afford it - but consumer understanding of access is limited. In early 2023, Releaf investigated the knowledge of the UK population with a survey about medical cannabis, where we discovered that only 34% of the population knew British citizens could get a medical cannabis prescription delivered through their letterbox via a private doctor. Advertising laws for medical cannabis companies are tightly controlled and fairly restrictive, leaving patient numbers in the UK far lower than in countries with similar policies, such as Germany and Australia.

03. 11. 2023

Medical Cannabis Awareness Week: The Patient Conference with Drug Science

This November marks the third year of celebrating Medical Cannabis Awareness Week - a whole week dedicated to highlighting the successes of the medical cannabis industry but also provides an opportunity to bring together all sectors for reflection and discussions. Drug Science, leaders of the T21 medical cannabis patient study are hosting The Patient Conference with The Medcan Family Foundation on November 3rd at Conway Hall in London. Tickets are available here.